ArticleBriefings in bioinformatics2026
An integrative association analysis for complex diseases in underrepresented groups by leveraging the trans-ethnic genetic similarity.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cross-cohort insights into the association of handgrip strength transitions and burdens with cardiovascular disease risk.SSM - population health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Genome-wide association studies (GWASs) have been conducted primarily in European (EUR) populations, limiting insights into underrepresented groups such as East Asian (EAS), but cross-ancestry GWASs have demonstrated high trans-ethnic genetic similarity between EUR and non-EUR populations. To enhance association analysis power in EAS populations, we propose tranScore, a novel summary-statistics-based transfer learning method that leverages trans-ethnic genetic similarity through hierarchical modeling. By considering EUR as auxiliary population, tranScore performs joint testing of genetic effects in auxiliary and target populations via well-established P-value combination procedures. Simulations demonstrate that tranScore maintains control of type I error rates and provides substantial power gains for diverse genetic architectures, showing robustness against various challenges including incomplete SNP overlap and effect heterogeneity. In the real-data application of eight diseases from the China Kadoorie Biobank (CKB), after incorporating the genetic information of the EUR population, tranScore identified significantly more genes than the traditional score test which ignored such information. Approximately 41.9% of discovered genes were replicated in the Biobank Japan cohort. Overall, tranScore represents a flexible and powerful statistical approach for association analysis of complex diseases and traits through transfer learning of shared genetic similarities between the auxiliary and target populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.